Progress of inhibiting epithelial-mesenchymal transition in retinal pigment epithelial cells
Author:
Corresponding Author:

Affiliation:

Clc Number:

Fund Project:

National Key R&D Program of China(No.2017YFA0104101)

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    Epithelial-mesenchymal transition(EMT)of retinal pigment epithelial cells(RPE)plays a key role in proliferative vitreoretinopathy(PVR), and also decreases the therapeutic effect of anti-vascular endothelial growth factor(anti-VEGF)to choroidal neovascularization(CNV). In addition, cells transplantation has been becoming a potential therapeutic method to treat age-related macular degeneration(AMD), and some cells sources like human embryonic stem cells(hESC)or induced pluripotent stem cell(iPSC)induced RPE cells, and fetal RPE cells have been attempted. However, EMT, as a common problem, decreases cells proliferation and differentiation efficiency, and it will reduce therapeutic effect and the number of therapeutic populations. So, in this article, we reviewed some possible methods to inhibit EMT.

    Reference
    Related
    Cited by
Get Citation

Duo Li, Han Shen, Song-Tao Yuan, et al. Progress of inhibiting epithelial-mesenchymal transition in retinal pigment epithelial cells. Guoji Yanke Zazhi( Int Eye Sci) 2018;18(12):2160-2164

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
Publication History
  • Received:July 18,2018
  • Revised:November 05,2018
  • Adopted:
  • Online: November 19,2018
  • Published: